FENC
FENNEC PHARMACEUTICALS INC.
Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
75
Buys
3
Sells
47
Largest Trade
N/A
Insiders
6
Institutional Funds
72
Inst. Value
$1M+
Activist Filings
12
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $500K+ | 89K | $10.82 | Apr 5, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 41K | $10.78 | Apr 3, 2024 |
| Andrade Robert | CHIEF FINANCIAL OF… | BUY | N/A | 13K | — | Apr 3, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | BUY | N/A | 29K | — | Apr 3, 2024 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 4K | $2.31 | Mar 27, 2024 |
| RALLIS CHRIS A | Director | SELL | $15K–$50K | 2K | $10.97 | Mar 27, 2024 |
| Andrade Robert | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 14K | $10.90 | Mar 27, 2024 |
| Andrade Robert | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 14K | $11.00 | Mar 25, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $15K–$50K | 4K | $11.55 | Dec 29, 2023 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | EXERCISE | $1K–$15K | 9K | $1.59 | Dec 29, 2023 |
| RALLIS CHRIS A | Director | SELL | $15K–$50K | 1K | $10.90 | Dec 28, 2023 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 3K | $1.59 | Dec 28, 2023 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 269 | $8.25 | Nov 21, 2023 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 25K | $7.76 | Nov 9, 2023 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 673 | $7.85 | Aug 18, 2023 |
| RALLIS CHRIS A | Director | SELL | $50K–$100K | 7K | $8.17 | Jul 24, 2023 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 17K | $0.72 | Jul 24, 2023 |
| RALLIS CHRIS A | Director | SELL | $15K–$50K | 2K | $8.47 | Jul 6, 2023 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 5K | $0.96 | Jul 6, 2023 |
| Andrade Robert | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 25K | $8.93 | Jun 30, 2023 |
| Andrade Robert | CHIEF FINANCIAL OF… | EXERCISE | $50K–$100K | 25K | $2.45 | Jun 30, 2023 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 2K | $7.36 | May 19, 2023 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 29K | $9.61 | Dec 30, 2022 |
| Andrade Robert | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 22K | $9.60 | Dec 30, 2022 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 333 | $7.99 | Nov 17, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 72 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Southpoint Capital Advisors LP | 2.7M | $1M+ | SH |
| Rosalind Advisors, Inc. | 2.6M | $1M+ | SH |
| AWM Investment Company, Inc. | 712K | $1M+ | SH |
| AIGH Capital Management LLC | 422K | $1M+ | SH |
| STATE STREET CORP | 353K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 270K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 204K | $1M+ | SH |
| Lion Point Capital, LP | 112K | $500K+ | SH |
| Potomac Capital Management, Inc. | 95K | $500K+ | SH |
| GENDELL JEFFREY L | 66K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 57K | $100K–$500K | SH |
| Hartford Financial Management Inc. | 51K | $100K–$500K | SH |
| Stonepine Capital Management, LLC | 50K | $100K–$500K | SH |
| Hillsdale Investment Management Inc. | 44K | $100K–$500K | SH |
| BARCLAYS PLC | 37K | $100K–$500K | SH |
| VANGUARD GROUP INC | 36K | $100K–$500K | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 32K | $100K–$500K | SH |
| RHUMBLINE ADVISERS | 29K | $100K–$500K | SH |
| 1492 Capital Management LLC | 28K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 27K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 11, 2026
9.8%
2.7M shares
SC 13G/A · Jan 14, 2026
8.0%
2.7M shares
SC 13G · Nov 13, 2025
7.5%
2.1M shares
SC 13G/A · Feb 14, 2025
8.2%
2.3M shares
SC 13G/A · Feb 14, 2025
4.1%
1.1M shares
SC 13G/A · Nov 14, 2024
7.0%
1.9M shares
SC 13G/A · Nov 13, 2024
5.5%
1.5M shares
SC 13G · Jun 27, 2024
5.2%
1.4M shares
SC 13G · Feb 14, 2024
0.0%
1.4M shares
SC 13G/A · Feb 14, 2023
9.2%
2.4M shares
SC 13G/A · Feb 14, 2022
9.3%
2.4M shares
SC 13G/A · Feb 11, 2022
4.6%
1.2M shares